Cargando…
Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
There are few published data on long-term treatment with sirolimus in lymphangioleiomyomatosis (LAM). The objective of this study was to describe the long-term effect of sirolimus in a series of LAM patients followed up in a referral centre, focusing on pulmonary function. We retrospectively reviewe...
Autores principales: | Revilla-López, Eva, Berastegui, Cristina, Méndez, Alejandra, Sáez-Giménez, Berta, Ruiz de Miguel, Victoria, López-Meseguer, Manuel, Monforte, Victor, Bravo, Carlos, Pujana, Miguel Angel, Ramon, Maria Antonia, Gómez-Ollés, Susana, Roman, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119464/ https://www.ncbi.nlm.nih.gov/pubmed/33986388 http://dx.doi.org/10.1038/s41598-021-89562-0 |
Ejemplares similares
-
Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023) -
Near-normal aerobic capacity in long-term survivors after lung transplantation
por: Saez-Gimenez, Berta, et al.
Publicado: (2021) -
Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation
por: Berastegui, Cristina, et al.
Publicado: (2020) -
Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
por: Aghaeimeybodi, Fatemeh, et al.
Publicado: (2019) -
Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)